FDA reviewing safety of Botox - EON: "Washington - After reports of death and serious reactions, the U.S. Food and Drug Administration (FDA) said on Friday they were reviewing the safety of Allergan Inc’s Botox and a competing product.
The FDA said that an unspecified number of deaths and hospitalizations occured. most of the reported deaths were in children who were being treated for cerebral palsy-associated limb spasticity with botox, a use which is not approved in the U.S."